Melanoma stem cells’ evasive talents
Melanoma, if not detected in its early stages, transforms into a highly deadly, treatment-resistant cancer. Although the immune system initially responds to melanoma and mounts anti-tumor attacks, these assaults are generally ineffective, allowing more advanced melanomas to win the battle and spread beyond the primary site. Now, researchers at Children’s Hospital Boston and Brigham and Women’s Hospital (BWH) shed light on how melanomas stimulate, yet ultimately evade, a patient’s immune system. Their work, published online January 12 by the journal Cancer Research, also suggests ways drugs might block these tactics.
Related News:
Research Reveals How Melanoma Stem Cells Shield Themselves From Immune Attack
Explaining The Persistence Of Melanoma: Each Melanoma Cell Capable Of ‘Cancer Stem Cell’ Behavior
Each melanoma cell capable of cancer stem cell behavior: Study